Alto Neuroscience, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $48.3M |
| FY2023 | $16.8M | $86.6M | $82.5M |
| FY2024 | $26.1M | $177.5M | $168.2M |
| FY2025 | $33.5M | $184.7M | $176.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $48.3M |
| FY2023 | $16.8M | $86.6M | $82.5M |
| FY2024 | $26.1M | $177.5M | $168.2M |
| FY2025 | $33.5M | $184.7M | $176.5M |